Our faculty secure major research grants from various National Institutes of Health as well as private sources.
Chelsie Armbruster, PhD
Genetic susceptibility to mucosal infections with aging. Chelsie Armbruster (Co-Principal Investigator). NIAID-R21. $438,625. 6/1/2020-5/1/2022.
Conserved Proteus mirabilis genetic requirements for colonization of the catheterized urinary tract. Chelsie Armbruster (Principal Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $1,684,580. 9/1/2019-5/1/2024.
Genetic susceptibility to mucosal infections with aging. Elsa Bou Ghanem (Co-Principal Investigator). NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. $438,625. 6/1/2020-5/1/2022.
The efficacy of Liposomal Encapsulation of Polysaccharides pneumococcal vaccine in protecting aged hosts against invasive Streptococcus pneumoniae infections in murine models. Elsa Bou Ghanem (Co-Principal Investigator). NIA-R21. $436,310. 9/1/2019-6/1/2021.
The role of the extracellular adenosine pathway in age-driven decline in polymorphonuclear leukocyte (PMN) anti-pneumococcal responses. Elsa Bou Ghanem (Co-Principal Investigator). The University at Buffalo CTSI Translational Pilot Studies Program. $40,000. 4/1/2019-4/1/2020.
The role of extracellular adenosine in age-driven susceptibility to S. pneumoniae lung infection. Elsa Bou Ghanem (Principal Investigator). NIA-R00. $453,576. 9/1/2018-6/1/2021.
TARGETING M. CATARRHALIS FOR PREVENTION AND TREATMENT OF OTITIS MEDIA. Anthony Campagnari (Principal Investigator). National Institutes of Deafness and Communicative Disorders. $1,982,425. 5/1/2016-4/1/2021.
Pneumococcal transition from nasopharyngeal biofilm carriage to otitis media. Anthony Campagnari (Principal Investigator). NIH/NIDCD. $1,840,000. 3/1/2014-2/1/2019.
Evaluation of a Specific Cytotoxic Agent and Identification of a New Targetable Receptor for Human TripleNegative Breast Cancer. Terry Connell (Co-Investigator). Dept. of Defense, BCRP, Breakthrough Award Levels 1. $375,000. 4/1/2018-3/1/2020.
Specific induction of lethal autophagy in triple-negative breast cancer cells. Terry Connell (Principal Investigator). National Cancer Institute, NIH. $275,000. 4/1/2017-3/1/2019.
Regulation of Intrinsic Caspofungin Resistance in C. neoformans. John Panepinto (Principal Investigator). National Insitute of Allergy and Infectious Diseases. $412,353. 8/1/2018-7/1/2020.
Stress Responsive Reprogramming of Translating mRNA Pools in C. neoformans. John Panepinto (Principal Investigator). NIAID. $1,932,170. 5/1/2017-4/1/2022.
Control of Host-Induced C. neoformans Morphogenesis by Protein Arginine Methylation. John Panepinto (Principal Investigator). American Heart Association Founders Affiliate. $154,000. 1/1/2017-12/1/2019.